Human Bone Marrow-Derived Endothelial Cells

NBP-0210 Primary Cells
$700.00
Starting price per unit
Human Bone Marrow-Derived Endothelial Cells
In Stock 1ml
Product Type Human Endothelial cells
Viability >98% viable (Trypan Blue exclusion)
Storage Storage Conditions Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life Very stable in the Liquid Nitrogen Vapor Phase

Quick Actions

Quality Certified
Global Shipping Available
Technical Support Included

Product Overview

Description

Human Bone Marrow-Derived Endothelial Cells (BMECs) represent a unique and specialized subset of endothelial cells that are extracted from human bone marrow. These cells are crucial in forming the inner lining of blood vessels, where they serve as a dynamic barrier between circulating blood and surrounding tissues.

BMECs are integral to several physiological processes, such as vascular biology, where they contribute to the regulation of blood flow and the maintenance of vascular homeostasis. Their role in hematopoiesis is particularly important, as they provide a supportive microenvironment for the development and differentiation of blood cells. Additionally, BMECs are actively involved in tissue regeneration, participating in repair mechanisms following injury by promoting angiogenesis, the formation of new blood vessels from existing ones.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.

Key Features

Catalog Number: NBP-0210
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)

CELLS CHARACTERIZATION

-Express typical endothelial markers (e.g., CD31, VE-cadherin, vWF, CD146).

-Exhibit cobblestone morphology in culture.

-Capable of forming capillary-like structures (tube formation assay).

-Support angiogenesis and vascular remodeling.

-Respond to angiogenic growth factors (e.g., VEGF, bFGF).

-Can interact with hematopoietic stem cells and support their maintenance.

-Low immunogenicity compared to other endothelial sources.

Quick Facts
Product Type

Human Endothelial cells

Viability

>98% viable (Trypan Blue exclusion)

Applications

-Vascular tissue engineering and regenerative med…

Availability

In Stock • Global Shipping

Technical Specifications

Product Type
Human Endothelial cells
Viability
>98% viable (Trypan Blue exclusion)
Proliferative Capability
Primary cells capable of multiple passages when using recommended medium and proper handling
Storage Conditions
Storage Conditions Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life
Very stable in the Liquid Nitrogen Vapor Phase
Product Code
NBP-0210
Size/Format
1ml
Primary Applications
-Vascular tissue engineering and regenerative medicine. -Study of angiogenesis and vasculogenesis in vitro. -Models for blood vessel formation and function. -Cell-based therapies for ischemic diseases (e.g. myocardial infarction peripheral artery disease). -Co-culture systems to support hematopoietic stem cell expansion. -Drug screening for angiogenic or anti-angiogenic compounds. -Research on endothelial dysfunction and vascular pathologies.

Applications & Use Cases

Primary Applications
-Vascular tissue engineering and regenerative medicine. -Study of angiogenesis and vasculogenesis in vitro. -Models for blood vessel formation and function. -Cell-based therapies for ischemic diseases (e.g.

Suitable for -vascular tissue engineering and regenerative medicine. -study of angiogenesis and vasculogenesis in vitro. -models for blood vessel formation and function. -cell-based therapies for ischemic diseases (e.g. studies and research applications

myocardial infarction

Suitable for myocardial infarction studies and research applications

peripheral artery disease). -Co-culture systems to support hematopoietic stem cell expansion. -Drug screening for angiogenic or anti-angiogenic compounds. -Research on endothelial dysfunction and vascular pathologies.

Suitable for peripheral artery disease). -co-culture systems to support hematopoietic stem cell expansion. -drug screening for angiogenic or anti-angiogenic compounds. -research on endothelial dysfunction and vascular pathologies. studies and research applications

Research Areas
In Vitro Studies

Cell culture and screening applications

Molecular Biology

Gene expression & signaling studies

Drug Discovery

Screening & validation studies

Disease Modeling

Pathophysiology research

Support & Resources

Technical Support

Our experts are available for technical questions and protocol assistance.

Contact Support
Documentation

Access product datasheets, protocols, and certificates.

Request Documentation
Shipping & Logistics

Temperature-controlled shipping to 40+ countries worldwide.

Shipping Info
FAQ & Resources

Find answers to common questions and optimization tips.

View FAQs

Our Worldwide Locations

Find a distributor near you

MoreBio

MoreBio

Advancing Life Science, Globally

Address F810, Testa Tower, 25, Misagangbyeonseo-ro
Hanam-si, Gyeonggi-do, Republic of Korea, 12918
Korea
Contact yhwoo@morebio.co.kr
+82-2-406-2942
+82-31-735-2944